Detalhe da pesquisa
1.
A real-life study of daratumumab-bortezomib-dexamethasone (D-VD) in lenalidomide exposed/refractory multiple myeloma patients: a report from the Triveneto Myeloma Working Group.
Ann Hematol
; 103(1): 125-132, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37731147
2.
Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myeloma.
Blood
; 137(22): 3027-3036, 2021 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33739404
3.
Antibody, cell-mediated response and infection susceptibility in allogeneic hematopoietic stem cell recipients after COVID-19 mRNA vaccination.
Transpl Infect Dis
; 25(2): e14003, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36748718
4.
Stem Cells mobilization and collection in allogeneic related and unrelated donors: a single center experience with focus on plerixafor.
Transfus Apher Sci
; 62(6): 103845, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37953206
5.
Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials.
Hematol Oncol
; 40(4): 704-715, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35608183
6.
Treosulfan compared with reduced-intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial.
Am J Hematol
; 97(8): 1023-1034, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35617104
7.
Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial.
Lancet Oncol
; 22(12): 1705-1720, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34774221
8.
Carfilzomib, bendamustine, and dexamethasone in patients with advanced multiple myeloma: The EMN09 phase 1/2 study of the European Myeloma Network.
Cancer
; 127(18): 3413-3421, 2021 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34181755
9.
Allogeneic Hemopoietic Stem Cell Transplants in Patients with Acute Myeloid Leukemia (AML) Prepared with Busulfan and Fludarabine (BUFLU) or Thiotepa, Busulfan, and Fludarabine (TBF): A Retrospective Study.
Biol Blood Marrow Transplant
; 26(4): 698-703, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31875522
10.
Clofarabine and Treosulfan as Conditioning for Matched Related and Unrelated Hematopoietic Stem Cell Transplantation: Results from the Clo3o Phase II Trial.
Biol Blood Marrow Transplant
; 26(2): 316-322, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31605823
11.
Bortezomib, cyclophosphamide, dexamethasone versus lenalidomide, cyclophosphamide, dexamethasone in multiple myeloma patients at first relapse.
Br J Haematol
; 188(6): 907-917, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31898319
12.
Outcome of paraosseous extra-medullary disease in newly diagnosed multiple myeloma patients treated with new drugs.
Haematologica
; 105(1): 193-200, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31221778
13.
First-line therapy with either bortezomib-melphalan-prednisone or lenalidomide-dexamethasone followed by lenalidomide for transplant-ineligible multiple myeloma patients: a pooled analysis of two randomized trials.
Haematologica
; 105(4): 1074-1080, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31248973
14.
Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patients.
BMC Cancer
; 20(1): 1140, 2020 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33234127
15.
Antiemetic prophylaxis in patients undergoing hematopoietic stem cell transplantation: a multicenter survey of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) transplant programs.
Ann Hematol
; 99(4): 867-875, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32036421
16.
Busulfan- or Thiotepa-Based Conditioning in Myelofibrosis: A Phase II Multicenter Randomized Study from the GITMO Group.
Biol Blood Marrow Transplant
; 25(5): 932-940, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30579966
17.
Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease.
N Engl J Med
; 374(1): 43-53, 2016 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26735993
18.
Assessment and prevention of cytomegalovirus infection in allogeneic hematopoietic stem cell transplant and in solid organ transplant: A multidisciplinary consensus conference by the Italian GITMO, SITO, and AMCLI societies.
Clin Transplant
; 33(10): e13666, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31310687
19.
Long-Term Follow-Up of a Donor versus No-Donor Comparison in Patients with Multiple Myeloma in First Relapse after Failing Autologous Transplantation.
Biol Blood Marrow Transplant
; 24(2): 406-409, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29032267
20.
Impact of New Drugs on the Long-Term Follow-Up of Upfront Tandem Autograft-Allograft in Multiple Myeloma.
Biol Blood Marrow Transplant
; 24(1): 189-193, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28987930